ORGANIZERS:

Michael Linial, The Hebrew University of Jerusalem
Zohar Yakhini, Technion and Agilent Laboratories

 

This joint GlycoHIT-HUJI Symposium will bring together a group of leading scientists in the field of glycobiology to discuss results and new directions in the field, including measurement approaches as well as biological implications and the role of glycosylation in various processes in living organisms.

Protein glycosylation plays a major role in regulating intercellular signalling, cell migration and adhesion and other important biological processes. Differences in glycosylation were observed in several studies comparing cancer samples to normal equivalents, and glyco biomarkers are currently being studied as potential early signals of cancer development. Furthermore, a large majority of protein therapeutics are glycoproteins for which the exact glycosylation pattern affects the treatment's success and safety. Protein glycosylation and approaches to measuring and controlling it therefore represent important current and future research directions within medical science and life science in general.

 

SPEAKERS:

Pilar Blasco, Spanish National Research Council, CSIS Madrid
Anne-Lise Børresen-Dale, Norwegian Radium Hospital
Lokesh Joshi, the National University of Ireland
Janne Lehtiö, Karolinska Institute
Kirk Leister, Bristol-Myers Squibb
Koby Rachmilewitz, The Hebrew University of Jerusalem
Pauline Rudd, National Institute for Bioprocessing Research and Training
Boaz Tirosh, The Hebrew University of Jerusalem